The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 18, 2012
Filed:
Oct. 30, 2006
Amjad Ali, Freehold, NJ (US);
Julianne A. Hunt, Scotch Plains, NJ (US);
Florida Kallashi, Laurence Harbor, NJ (US);
Jennifer Kowalchick, Clark, NJ (US);
Dooseop Kim, Westfield, NJ (US);
Cameron J. Smith, Lawrenceville, NJ (US);
Peter J. Sinclair, Scotch Plains, NJ (US);
Ramzi F. Sweis, Franklin Park, NJ (US);
Gayle E. Taylor, Jersey City, NJ (US);
Christopher F. Thompson, Clark, NJ (US);
Liya Chen, East Brunswick, NJ (US);
Nazia Quraishi, Vienna, VA (US);
Amjad Ali, Freehold, NJ (US);
Julianne A. Hunt, Scotch Plains, NJ (US);
Florida Kallashi, Laurence Harbor, NJ (US);
Jennifer Kowalchick, Clark, NJ (US);
Dooseop Kim, Westfield, NJ (US);
Cameron J. Smith, Lawrenceville, NJ (US);
Peter J. Sinclair, Scotch Plains, NJ (US);
Ramzi F. Sweis, Franklin Park, NJ (US);
Gayle E. Taylor, Jersey City, NJ (US);
Christopher F. Thompson, Clark, NJ (US);
Liya Chen, East Brunswick, NJ (US);
Nazia Quraishi, Vienna, VA (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.